# Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

> clinical trial · VERIFIED · 2026-07-06

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Prostate Cancer

- Company: National Cancer Institute (NCI)
- Sector: Prostate Cancer
- Primary source: https://clinicaltrials.gov/study/NCT03976843

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.